Theabrownin Inhibits Cell Cycle Progression and Tumor Growth of Lung Carcinoma through c-myc-Related Mechanism
Li Zhou(Zhejiang Chinese Medical University), Thomas Efferth(Johannes Gutenberg University Mainz)
Cited by 52
Related Papers
The role of p53 in cancer drug resistance and targeted chemotherapy
|Oncotarget|2016|580
Potential of Central, Eastern and Western Africa Medicinal Plants for Cancer Therapy: Spotlight on Resistant Cells and Molecular Targets
|Frontiers in Pharmacology|2017|142
Inhibition of c-MYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells
|Oncotarget|2015|84
Anti-Proliferative and Apoptosis-Inducing Effect of Theabrownin against Non-small Cell Lung Adenocarcinoma A549 Cells
|Frontiers in Pharmacology|2016|56